Chondroitin sulfate liposome: clustering toward high functional efficiency

Area of Science:

• Biochemistry
• Drug Delivery
• Glycobiology

Background:

• Chondroitin sulfate (CS) is a polysaccharide chain with specific binding properties.
• Different CS structures, like CSA and CSE, interact with distinct bioactive molecules, including VAR2CSA and RPTPσ.
• Targeted delivery of CS-binding molecules remains a challenge.

Purpose of the Study:

• To develop a novel liposomal drug delivery system for chondroitin sulfate (CS).
• To functionalize CS with phosphatidylethanolamine (PE) and incorporate it into liposomes.
• To evaluate the efficiency and specificity of CS-liposomes for delivering CS-binding molecules.

Main Methods:

• Modification of CSA and CSE with phosphatidylethanolamine (PE).
• Incorporation of CS-PE into liposomes.
• Inhibition ELISA to assess binding affinity to VAR2CSA and RPTPσ.
• Cellular uptake studies using RPTPσ-expressing HEK293T cells.

Main Results:

• Efficient incorporation of CS-PE into liposomes.
• Enhanced specific binding of CSA and CSE liposomes to VAR2CSA and RPTPσ, respectively, compared to free CS.
• Specific cellular uptake of CSE liposomes into RPTPσ-expressing cells.

Conclusions:

• CS-liposomes represent a novel and effective drug delivery system.
• This system demonstrates enhanced delivery of CS-binding molecules.
• The findings open avenues for targeted therapies involving CS-protein interactions.